Shabnam Baig

Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

J. Scott Miners, Emma L. Ashby, Shabnam Baig et al. · PubMed · 2009 · 164 citations · Full text

Angiotensin-converting Enzyme Levels, Neurochemical Biomarkers, Csf Ace +19

Distribution and Expression of Picalm in Alzheimer Disease

Shabnam Baig, Sally A. Joseph, Hannah Tayler et al. · Journal of Neuropathology & Experimental Neurology · 2010 · 115 citations · Full text

Neurochemical Biomarkers, Synaptic Signaling, Cellular Physiology +22

Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease

Shabnam Baig, Gordon Wilcock, Seth Love · Acta Neuropathologica · 2005 · 107 citations

Neurodegenerative Diseases, Alzheimer's Disease, Molecular Neuroscience +9

Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity

J. Scott Miners, Shabnam Baig, Hannah Tayler et al. · Journal of Neuropathology & Experimental Neurology · 2009 · 106 citations

Sporadic Alzheimer Disease, Aging, Neurochemical Biomarkers +18

Endothelin-Converting Enzyme-2 Is Increased in Alzheimer’s Disease and Up-Regulated by Aβ

Jennifer C Palmer, Shabnam Baig, Patrick G. Kehoe et al. · American Journal Of Pathology · 2009 · 99 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Endothelin-converting Enzyme-2 Is +7